2014
DOI: 10.1155/2014/569259
|View full text |Cite
|
Sign up to set email alerts
|

Determinants of the Morning-Evening Home Blood Pressure Difference in Treated Hypertensives: The HIBA-Home Study

Abstract: Background. The morning home blood pressure (BP) rise is a significant asymptomatic target organ damage predictor in hypertensives. Our aim was to evaluate determinants of home-based morning-evening difference (MEdiff) in Argentine patients. Methods. Treated hypertensive patients aged ≥18 years participated in a cross-sectional study, after performing home morning and evening BP measurement. MEdiff was morning minus evening home average results. Variables identified as relevant predictors were entered into a m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 45 publications
0
9
0
Order By: Relevance
“…The baseline characteristics of each cohort appear in Tables S3 and S4 for untreated and treated participants, respectively. The median number (5th to 95th percentile interval) of home blood pressure measurements amounted to 48 (8-56) in Ohasama, 10 (2-34) in Tsurugaya, 12 in Didima, and 24 (22)(23)(24)(25)(26)(27)(28) in Buenos Aires. Among treated participants belonging to the Ohasama, Tsurugaya, and Buenos Aires cohorts, 80 (50.6%) were on monotherapy and 78 (49.4%) were on combination therapy taking a median of 1.0 drug per day.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…The baseline characteristics of each cohort appear in Tables S3 and S4 for untreated and treated participants, respectively. The median number (5th to 95th percentile interval) of home blood pressure measurements amounted to 48 (8-56) in Ohasama, 10 (2-34) in Tsurugaya, 12 in Didima, and 24 (22)(23)(24)(25)(26)(27)(28) in Buenos Aires. Among treated participants belonging to the Ohasama, Tsurugaya, and Buenos Aires cohorts, 80 (50.6%) were on monotherapy and 78 (49.4%) were on combination therapy taking a median of 1.0 drug per day.…”
Section: Resultsmentioning
confidence: 99%
“…The analysis included 144 (untreated/treated, 106/38) residents of Ohasama, Japan 21 ; 137 (75/62) inhabitants of the Tsurugaya district in Sendai, Japan 22 ; 36 (21/15) inhabitants of Didima, Greece 23 ; and 58 treated outpatients of a general hospital in Buenos Aires, Argentina. 24 All studies received ethical approval. Participants provided written informed consent.…”
Section: Study Populationmentioning
confidence: 99%
See 3 more Smart Citations